Cytokinetics Inc. buy Barclays PLC
Start price
23.05.24
/
50%
€46.40
Target price
23.05.25
€87.72
Performance (%)
-42.24%
End price
24.05.25
€26.80
Summary
This prediction ended on 24.05.25 with a price of €26.80. Massive losses of -42.24% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 1.905% | 1.905% | 34.422% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Barclays PLC from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
59.23%
20.03.26
20.03.26
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.60
03.09.25
03.09.25
€61.04
03.09.26
03.09.26
28.61%
20.03.26
20.03.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
84.48%
20.03.26
20.03.26